Canaccord Genuity Maintains Buy on Hinge Health, Raises Price Target to $100

Benzinga · 2d ago
Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $76 to $100.